Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

ISA 2022 and Al Amyloidosis View overview page

4:18
Considerations for transplantation in AL amyloidosis
Maximilian Steinhardt • 6 Sep 2022
1:47
Current and emerging antibody-based immunotherapies in AL amyloidosis
Maximilian Steinhardt • 6 Sep 2022
2:38
Unmet needs in imaging for the diagnosis of AL amyloidosis
Maximilian Steinhardt • 6 Sep 2022
5:38
Insights into the pathogenesis of amyloidosis from the proteome of renal amyloid plaques
Charalampos Charalampous • 7 Sep 2022
4:01
In vitro characterization of response to venetoclax in AL amyloidosis
Niels van Nieuwenhuijzen • 7 Sep 2022
2:17
Pre-symptomatic diagnosis of AL amyloidosis with biomarker-based screening in patients with MGUS
Silvia Mangiacavalli • 7 Sep 2022
0:57
Phenotypic variability & getting to the right diagnosis in AL amyloidosis
Marianna Fontana • 14 Sep 2022
3:16
The potential of AT-02 as a therapeutic strategy in ATTR & AL amyloidosis
Jonathan Wall • 14 Sep 2022
3:59
Using an iPSC-derived model to understand the mechanisms driving light chain-induced cardiotoxicity
Camille Vanessa Edwards • 7 Sep 2022
1:29
The impact of clonal features on the survival of patients with non-cardiac AL amyloidosis
Paolo Milani • 7 Sep 2022
2:14
Imaging modalities to diagnose and monitor AL & ATTR amyloidosis
Marianna Fontana • 14 Sep 2022
2:41
Optimizing the use of daratumumab in AL amyloidosis
Camille Vanessa Edwards • 7 Sep 2022
1:56
ISA session highlights: basic research on light chains & cardiotoxicity in amyloidosis
Stefano Ricagno • 6 Sep 2022
2:51
The role of protein dynamics and proteolysis in light chain amyloid aggregation
Stefano Ricagno • 6 Sep 2022
1:55
Factors predicting outcomes in patients with AL amyloidosis treated with daratumumab
Camille Vanessa Edwards • 7 Sep 2022
3:07
PET/CT imaging study of the amyloid-reactive peptide 124I-AT-01 to detect systemic amyloidosis
Jonathan Wall • 14 Sep 2022
The content of VJHemOnc is intended for healthcare professionals